Organizational Readiness for Transformational Partnerships in Biopharmaceutical Companies

This research explores biopharmaceutical companies' organizational readiness for transformational partnerships and more specifically, for the prevention of CMDs (phenomenon of interest). The researcher posited a relationship between organizational, leadership, and readiness factors and organizational readiness to engage in transformational partnerships within biopharmaceutical companies. A sequential, qualitative research design was utilized to maximize the assessment of the current state of organizational readiness for subunits of prevention and partnership in context. Results from a document analysis and semi-structured interviews, the researcher concluded that there are challenges for BC organizational-level readiness for effective and impactful achievement of SDG 3 via transformational partnerships that will have a significant impact on population health; however, a great deal of thought, effort, and motivation is present. These insights highlight the practice- and leadership-oriented elements that support more transformational, systems-level change.